Loading

Commentary Open Access
Volume 6 | Issue 1 | DOI: https://doi.org/10.46439/cancerbiology.6.069

Advances in glyconanotechnology based biomedical applications

  • 1Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA
+ Affiliations - Affiliations

Corresponding Author

Divya Kamath, dkamath@kumc.edu

Stefan H. Bossmann, sbossmann@kumc.edu

Received Date: January 02, 2025

Accepted Date: February 06, 2025

Abstract

There is an emerging awareness in cancer biology that glycobiology plays a significant, if not decisive role in oncogenesis, tumor survival, and proliferation. The human glycome is even more complex than the human genome, because glycans are synthesized as secondary gene products by sequentially acting glycosidases and glycosyltransferases. Glycans act as a communication system within the organism and between different organisms. In principle, nanotechnology has the potential of amplifying glycan interaction. By using the physical and chemical properties of nanoparticular systems, glyconanoparticles have revolutionized the biomedical research by developing platforms for cancer therapy, drug delivery, immunotherapy, biosensing and bioimaging. Here we comment on the most used glycans, and nanomaterials in glyconanotechnology, along with new insights. 

Author Information X